Diamond Hill Capital's Large Cap Fund underperformed the Russell 1000 Value Index in Q1 2025. The fund highlighted Abbott Laboratories as a top performer due to successful business execution and product developments, with its stock showing promising growth potential.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing